Advaxis, Inc. (ADXS) Saw a New 52-Week Low

0
58

The company is now down by 7.65%% since yesterday’s close of 3.79. The stock is trading at $3.50 significantly below $4.78, the stock’s 50 day moving average and impressively lower than the 200 day moving average of $6.63. The 50 day moving average moved down $-1.28 and the 200 day average moved down $-3.13.

Investors are more bullish on shares of Advaxis, Inc. recently if you pay attention to the downtick in short interest. The firm saw a fall in short interest of -15.79% as of September 29, 2017 from the last reporting period. Short shares decreased 1,568,524 over that timeframe. Days to cover decreased -5.0 to 5.0 and the percentage of shorted shares is 0.21% as of September 29.

Advaxis, Inc., launched on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors..

Additionally, here are a few investment firms who have increased or decreased their stake in (ADXS). Ubs Group Ag downsized its stake by selling 502 shares a decrease of 62.6% as of 06/30/2017. Ubs Group Ag currently owns 300 shares valued at $2,000. The value of the position overall is down by 71.4%. As of quarter end Vident Investment Advisory, LLC had acquired 78,100 shares growing its position 71.7%. The value of the investment in Advaxis, Inc. increased from $890,000 to $1,214,000 a change of $324,000 for the reporting period.

Franklin Street Advisors Inc /nc added to its position by buying 2,000 shares an increase of 3.5% in the quarter. Franklin Street Advisors Inc /nc controls 59,800 shares with a value of $250,000. The total value of its holdings decreased 33.3%. As of the end of the quarter Cutler Group LP had bought a total of 3,677 shares growing its holdings by 21.7%. The value in dollars went from $110,000 to $86,000 decreasing 21.8% quarter to quarter.

As of the last earnings report the EPS was $-2.29 and is projected to be $-2.23 for the current year with 41,065,000 shares outstanding. Next quarter’s EPS is forecasted to be $-0.58 with next year’s EPS anticipated to be $-2.35.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.